rdf:type |
|
lifeskim:mentions |
umls-concept:C0019592,
umls-concept:C0034814,
umls-concept:C0078442,
umls-concept:C0086418,
umls-concept:C0205409,
umls-concept:C0285540,
umls-concept:C0312740,
umls-concept:C0700624,
umls-concept:C1261322,
umls-concept:C1533691,
umls-concept:C2919009
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-8-24
|
pubmed:abstractText |
Skin mast cells, basophils and eosinophils are effector cells of acute and subacute allergic responses due to their capacity to produce a large number of (pro)inflammatory mediators. Histamine H1 receptor antagonists, such as epinastine (WAL 801 CL), have been described to partially exert antiallergic and antiinflammatory effects both in vivo and in vitro in addition to their antihistaminergic properties. The aim of the present study was to investigate whether epinastine could influence the in vitro activation of isolated human skin mast cells, basophils and eosinophils induced by different secretagogues.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1023-3830
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
112-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10807498-Basophils,
pubmed-meshheading:10807498-Cell Separation,
pubmed-meshheading:10807498-Dibenzazepines,
pubmed-meshheading:10807498-Eosinophils,
pubmed-meshheading:10807498-Female,
pubmed-meshheading:10807498-Histamine H1 Antagonists,
pubmed-meshheading:10807498-Humans,
pubmed-meshheading:10807498-Hypersensitivity,
pubmed-meshheading:10807498-Imidazoles,
pubmed-meshheading:10807498-Mast Cells,
pubmed-meshheading:10807498-Protein Kinase C,
pubmed-meshheading:10807498-Skin
|
pubmed:year |
2000
|
pubmed:articleTitle |
In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells.
|
pubmed:affiliation |
PsoriSol Centre for Dermatology and Allergy, Hersbruck, Germany. amon@psorisol.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|